Search Results - "Rulach, R."

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits by Rulach, R., Hanna, G.G., Franks, K., McAleese, J., Harrow, S.

“…In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local…”
Get full text

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic by Faivre-Finn, C., Fenwick, J.D., Franks, K.N., Harrow, S., Hatton, M.Q.F., Hiley, C., McAleese, J.J., McDonald, F., O'Hare, J., Peedell, C., Pope, T., Powell, C., Rulach, R., Toy, E.

“…Patients treated with curative-intent lung radiotherapy are in the group at highest risk of severe complications and death from COVID-19. There is therefore an…”
Get full text

The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma by Zhou, S., Chan, C., Lau, Y.C., Rulach, R., Dyab, H., Hendry, F., Wilson, C., Schipani, S., Lamb, C., Grose, D., James, A., Maxfield, C., Dempsey, M.-F., Paterson, C.

“…AIMSThe high negative predictive value of post-chemoradiation (CRT) positron emission tomography-computed tomography (PET-CT) is well established in head and…”
Get full text

UK Training in Clinical Oncology: The Trainees' Viewpoint by Casswell, G., Shakir, R., Macnair, A., O'Leary, B., Smith, F., Rulach, R., Bowden, C.

“…•Trainee satisfaction has increased; 81% rated their training ‘excellent’ or ‘good’.•Half of trainees felt their formal FRCR Part One training to be…”
Get full text

Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol by Zhou, S., Rulach, R., Hendry, F., Stobo, D., James, A., Dempsey, M.-F., Grose, D., Lamb, C., Schipani, S., Rizwanullah, M., Wilson, C., Lau, Y.C., Paterson, C.

“…To evaluate the implementation of 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) surveillance after (chemo)radiotherapy,…”
Get full text

Radiotherapy for Brain Metastases from Renal Cancer and Utility of Prognostic Indices: Real Life Experience from The Beatson West of Scotland Cancer Centre by Rulach, R, McLoone, P, Jones, R, Venugopal, B

Get full text

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions by Rulach, R., McLoone, P., Lumsden, G., McKay, S., MacLaren, V., Macphee, J., Moore, K., Omand, M., Sproule, M., Currie, S., Aitken, A., Ferguson, R., Valentine, R., Houston, P., Harrow, S., Hicks, J.

“…Stereotactic ablative body radiotherapy doses for peripheral lung lesions caused high toxicity when used for central non-small cell lung cancer (NSCLC). To…”
Get full text

5: What is the relationship between F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) characteristics and outcomes in continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC)? by Rulach, R, Fullerton, R, Han, S, Hendry, F, Colville, D, Jones, R

Get full text

Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck by Paterson, C., Thomson, M.C., Caldwell, B., Young, R., McLean, A., Porteous, S., Clark, S., Messow, C.M., Kean, S., Grose, D., Lamb, C., Rizwannullah, M., James, A., Schipani, S., Wilson, C., Rulach, R., Jones, R.

“…Radiotherapy-induced xerostomia (RIX) is a common and untreatable side effect of radiotherapy to the head and neck. Visco-ease™ mouth spray (Lamellar…”
Get full text

P-080Incidence of thrombo-embolism (TE) during neo-adjuvant chemotherapy in patients (pts) with oesophago-gastric adenocarcinoma (OGC): implications for surgery and survival by Rulach, R, Evans, J, McIntosh, D, Grose, D, Fullarton, G, shaw, M, MacKay, C, Craig, C, Graham, J

Get full text

SP-0842 EBRT for re-irradiation: Concepts and results by Rulach, R.

Get full text

Pancreatic cancer genomics: where can the science take us? by Graham, J.S., Jamieson, N.B., Rulach, R., Grimmond, S.M., Chang, D.K., Biankin, A.V.

“…The incidence of pancreatic ductal adenocarcinoma (PDAC) is steadily increasing and the annual death‐to‐incidence ratio approaches one. This is a figure that…”
Get full text

Toxicity and Efficacy of SABR using 50 Gy in 5 Fractions for Central, Inoperable Lung Tumours by Rulach, R.

Get full text

Thoracic re-irradiation dose constraints: early results from a literature review by Rulach, R., Fenwick, J., Harrow, S.

Get full text

Real world experience of third line docetaxel ± nintedanib post-nivolumab for treatment of metastatic NSCLC in the West of Scotland by Rulach, R., Mclaren, A., Clark, B.

Get full text

Multi-Criteria Optimisation is Effective at Reducing Dose to Organs at Risk in Non-small Cell Lung Cancer (NSCLC) Re-irradiation by Rulach, R., Chalmers, A., Harrow, S., Currie, S.

Get full text

86 - Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS) by Ansel, S., Rulach, R., Clark, B., Steele, N., Maclaren, V.

Get full text

Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS) by Ansel, S., Rulach, R., Clark, B., Steele, N., Maclaren, V.

Get full text

OC-0433 Positive predictive value of post radiotherapy FDG PET-CT is affected by treatment and HPV-status by Zhou, S., Chan, C., Dyab, H., Rulach, R., Hendry, F., Maxfield, C., Hendry, M.F., James, A., Lamb, C., Grose, D., Wilson, C., Schipani, S., Lau, Y.C., Paterson, C.

Get full text

382P The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: Final results from a phase I study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma (GBM) by Tiu, C., Tzankov, A., Plummer, R., Rulach, R., Vivanco, I., Mulholland, P.J., Gurel, B., Figueiredo, I., Haris, N. Md, Anderson, S., Bachmann, F., Engelhardt, M., Kaindl, T., Lane, H., Litherland, K., Pognan, C., Berezowska, S., Evans, J., Kristeleit, R., Lopez, J.S.

Get full text